AbbVie | ABBV - Costo Del Venduto

Prezzo Delle Azioni
204.24
Cambio Giornaliero
6.55 3.31%
Mensile
-4.17%
Annuale
4.68%
Q2 Previsione
194.46




Costo Del Venduto Cambiamento Data
AbbVie USD 4.22B 329M 2026-03
Abbott USD 5.3B 380M 2026-03
ALKERMES USD 46.21M 5.38M 2025-12
Amgen USD 1.79B 128M 2025-12
AstraZeneca USD -204M 3.48B 2026-03
Biogen USD 797.5M 302M 2026-03
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Coherus Biosciences USD 4.04M 324K 2025-12
Eisai JPY 51.08B 5.56B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Gilead Sciences USD 1.62B 50M 2025-12
GlaxoSmithKline GBP 1.88B 736M 2026-03
Infinity Pharmaceuticals USD 352K 89K 2023-06
J&J USD 8.07B 103M 2026-03
Medtronic USD 3.61B 83M 2025-12
Merck USD 3.32B 531M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Novartis USD 3.54B 3M 2025-12
Pacira USD 54.62M 6.02M 2025-12
Perrigo USD 747.4M 81.2M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
UCB EUR 1.07B 146M 2025-12
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
United Therapeutics USD 474.7M 373.8M 2025-12
Vertex Pharmaceuticals USD 466M 51.2M 2025-12
Zoetis USD 743M 60M 2025-12